Lymphangiogenesis and Angiogenesis in Conventional Renal Cell Carcinoma: Association with Vascular Endothelial Growth Factors A to D Immunohistochemistry

Urology

Volumn 71, Issue 4, 2008, Pages 749-754

  Iwata, Takahisa ^a   Miyata, Yasuyoshi ^a   Kanda, Shigeru ^b   Nishikido, Masaharu ^a   Hayashi, Tomayoshi ^c   Sakai, Hideki ^a   Kanetake, Hiroshi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagasaki Graduate School of Health Sciences   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIBODY; MONOCLONAL ANTIBODY D2-40; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D;

ANGIOGENESIS; ARTICLE; CANCER STAGING; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LYMPH VESSEL; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 41149084403     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.10.063     Document Type: Article

References (28)

1. Saharinen P., Tammela T., Karkkainen M.J., et al. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25 (2004) 387-395
2. Alitalo K., Mohla S., and Ruoslahti E. Lymphangiogenesis and cancer: meeting report. Cancer Res 64 (2004) 9225-9229
3. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 14-25
4. Mould A.W., Tonks I.D., Cahill M.M., et al. VEGF-B gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis Rheumatol 48 (2003) 2660-2669
5. Silvestre J.S., Tamarat R., Ebrahimian T.G., et al. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ Res 93 (2003) 114-123
6. Skobe M., Hawighorst T., Jackson D.G., et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7 (2001) 192-198
7. Stacker S.A., Caesar C., Baldwin M.E., et al. VEGF-D promotes the metastasis spread of tumor cells via the lymphatics. Nat Med 7 (2001) 186-191
8. Nagy J.A., Vasile E., Feng D., et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196 (2002) 1497-1506
9. Cursiefen C., Chen L., Borges L.P., et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113 (2004) 1040-1050
10. Cao Y., Linden P., Farnebo J., et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 95 (1998) 14389-14394
11. Rissanen T.T., Markkanen J.E., Gruchala M., et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 92 (2003) 1098-1106
12. Uzzo R.G., Cherullo E.E., Myles J., et al. Renal cell carcinoma invading the urinary collecting system: implications for staging. J Urol 167 (2002) 2392-2396
13. Strohmeyer D. Pathophysiology of tumor angiogenesis and its relevance in renal cell cancer. Anticancer Res 19 (1999) 1557-1561
14. Paradis V., Lagha N.B., Zeimoura L., et al. Expression of vascular endothelial growth factor in renal cell carcinomas. Virchows Arch 436 (2001) 351-356
15. Jacobsen J., Grankvist K., Rasmuson T., et al. Expression of vascular endothelial growth factor protein in human renal cell carcinoma. BJU Int 93 (2004) 297-302
16. Saharinen P., Tammela T., Karkkainen M.J., et al. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25 (2004) 387-395
17. Miyata Y., Kanda S., Ohba K., et al. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. J Urol 176 (2006) 348-353
18. Miyata Y., Kanda S., Ohba K., et al. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D. Clin Cancer Res 12 (2006) 800-806
19. Fuhrman S.A., Lasky L.C., and Limas C.L. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Pathol 6 (1982) 655-663
20. Trojan L., Michael M.S., Rensch F., et al. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). J Urol 172 (2004) 103-107
21. Leu A.J., Berk D.A., Lymboussaki A., et al. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60 (2000) 4324-4327
22. Beasley N.J., Prevo R., Banerji S., et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62 (2002) 1315-1320
23. Hirakawa S., Kodama S., Kunstfeld R., et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201 (2005) 1089-1099
24. Kubo H., Cao R., Brakenhielm E., et al. Blockage of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2 induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci USA 99 (2002) 8868-8873
25. Lee C.G., Link H., Baluk P., et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances T(H)2-mediated sensitization and inflammation in the lung. Nat Med 10 (2004) 1095-1103
26. Gunningham S.P., Currie M.J., Han C., et al. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia. Cancer Res 61 (2001) 3206-3211
27. Tsuchiya N., Sato K., Akao T., et al. Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma. Tohoku J Exp Med 195 (2001) 101-113
28. Bellomo D., Headrick J.P., Silins G.U., et al. Mice lacking the vascular endothelial growth factor-B gene (VEGF-B) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res 86 (2000) E29-E35